Cited by 95Extracellular vesicles in diseaseNanoparticle-Based Drug DeliveryMesenchymal stem cell research

Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context

Open access
Esmaeili, Abazar, Alini, Mauro, Baghaban Eslaminejad, Mohamadreza, Hosseini, Samaneh·2022·Stem Cell Research & Therapy

Abstract

Extracellular vesicles (EVs) are advanced therapeutic strategies that can be used to efficiently treat diseases. Promising features of EVs include their innate therapeutic properties and ability to be engineered as targeted drug delivery systems. However, regulation of EV uptake is one challenge of EV therapy that must be overcome to achieve an efficient therapeutic outcome. Numerous efforts to improve the factors that affect EV uptake include the selection of a cell source, cell cultivation procedure, extraction and purification methods, storage, and administration routes. Limitations of rapid clearance, targeted delivery, and off-targeting of EVs are current challenges that must be circumvented. EV engineering can potentially overcome these limitations and provide an ideal therapeutic use for EVs. In this paper, we intend to discuss traditional strategies and their limitations, and then review recent advances in EV engineering that can be used to customize and control EV uptake for future clinical applications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-022-02806-2

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A substantial quantity of EVs is needed to address CNS diseases, particularly in cases where the affected region is sizable.

    “Furthermore, a substantial quantity of EVs is needed to address CNS diseases, particularly in cases where the affected region is sizable.”

    From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [332]

    The EV administration routes section (page unavailable) says systemic delivery generally requires a higher total EV dose than local delivery and discusses EV delivery to the brain. It does not say that CNS diseases require a substantial quantity of EVs specifically, or that a larger affected region increases the quantity needed. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Esmaeili, A., Alini, M., Baghaban Eslaminejad, M., & Hosseini, S.
Affiliations
  • University of Science and Culture (IR)
  • AO Foundation (CH)
  • Royan Institute (IR)
Corresponding author
Hosseini, Samaneh
Venue
Stem Cell Research & Therapy
Published
2022-03-28
Volume
13
Issue
1
Pages
129-129
ISSN
1757-6512 (ISSN-L)
OpenAlex
W4221108293
Cited by
94
References
122
Citations by year
2026: 23 · 2025: 24 · 2024: 25 · 2023: 15 · 2022: 7
FWCI
1.85
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
extracellular vesicles, EV uptake, EV engineering, targeted drug delivery, cell source selection, cell culture, route of administration, off-target effects, clinical translation
MeSH terms
Extracellular Vesicles, Biological Transport, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review